Archana Jatkar, Associate Secretary General - Indian Pharmaceutical Alliance (IPA), has co-authored a comprehensive article in SouthViews on the importance of a balanced intellectual property framework to improve patients’ access to affordable, quality-assured medicines. Read

Ready for a masterclass on the future of the Indian pharmaceutical industry?. ​Get exclusive insights on how to transform the industry and lead on the global stage. We're talking innovation, regulatory excellence, and healthcare impact with three of the biggest names in the

Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.

Watch Now - @EconomicTimes' #CornerOfficeConversation. Tune into this unmissable conversation with Dr. Sharvil Patel (MD, @ZydusUniverse & VP - Indian Pharmaceutical Alliance), Aman Mehta (MD, @TorrentPharmaIn) and @namitathapar (Executive Director, @emcure), hosted by

RT @namitathapar: This half hour podcast covers our thoughts on pharma industry. @VikasReports from @EconomicTimes , one of the most respec….

Lung cancer remains one of the deadliest forms of cancer, accounting for over 70,000 deaths annually in India alone. While smoking continues to be a key risk factor, rising pollution levels and late-stage diagnoses have made this disease a growing public health concern, even

Want to know what's next for the Indian pharma? . Tune into a special edition of @EconomicTimes' #CornerOfficeConversation where Dr. Sharvil Patel (MD, @ZydusUniverse & VP - Indian Pharmaceutical Alliance), Aman Mehta (MD, @TorrentPharmaIn) and @namitathapar (Executive Director,.

Hepatitis remains a silent but serious public health challenge. From national vaccination drives to the development of cost-effective antivirals. India is making significant strides in the fight against viral hepatitis, with stronger awareness, improved diagnostics, and more

India has earned its place as a global leader in pharmaceutical innovation, but maintaining that edge requires professionals who are not just technically sound, but also agile, industry-ready, and future-focused. To bridge this gap, the Indian Pharmaceutical Alliance (IPA), along

India earned global recognition as the Pharmacy of the World by supplying affordable, high-quality medicines to over 200 countries. Now, it’s time to lead once again by building a future that’s not only healthier, but also more sustainable. In his article in Pharma Bio World,

India’s IP framework demonstrates that innovation and public health can advance hand in hand. With clear, purposeful safeguards, our patent system supports genuine research while ensuring access to life-saving medicines. This is innovation with responsibility and integrity.

Patents in India: Balancing Innovation and Access. Archana Jatkar, Associate Secretary General at the Indian Pharmaceutical Alliance, shares her insights on how India’s evolving patent ecosystem is shaping the future of innovation while ensuring affordable access to medicines.

Proud to witness Indian innovation stepping into the global spotlight. Glenmark’s licensing agreement with @abbvie for ISB 2001 stands as one of the largest in its category, a testament to India’s growing leadership in biologics. As a trispecific antibody therapy in oncology, ISB.

Obesity is fast becoming one of India’s most critical public health challenges. As a major driver of diabetes and cardiovascular diseases, it demands immediate, systemic, and sustained action. At the Diabetes Symposium hosted by the @IIMAhmedabad, Mr. @sjainindjain, Secretary

India’s approach to intellectual property reflects a thoughtful balance, encouraging innovation while ensuring timely access to affordable medicines. ​. Our patent framework promotes genuine innovation, discourages unwarranted monopolies, and fosters healthy competition in the